Evidence map›Paper›PMID 34012427›Full record

ArticleFrontiers in microbiology2021

Infant-Associated Bifidobacterial β-Galactosidases and Their Ability to Synthesize Galacto-Oligosaccharides.

Valentina Ambrogi, Francesca Bottacini, John O'Callaghan, Eoghan Casey, Justin van Breen, Barry Schoemaker, Linqiu Cao, Bas Kuipers, Mary O'Connell Motherway, Margriet Schoterman and 1 more

Open access · goldAbstract read
In one paragraph

Article in Frontiers in microbiology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
1.5field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 18 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Unlocking New Approaches to Urolithiasis ManagementCurrent pharmaceutical biotechnology · 2024
    Review
  6. Review
  7. Review
  8. Review
  9. β-galactosidase GALA fromBioengineered · 2021
    Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 4 institutions in 2 countries.

Valentina AmbrogiAPC Microbiome Ireland, University College Cork, Cork, Ireland.
Francesca BottaciniAPC Microbiome Ireland, University College Cork, Cork, Ireland.
John O'CallaghanSchool of Microbiology, University College Cork, Cork, Ireland.
Eoghan CaseyAPC Microbiome Ireland, University College Cork, Cork, Ireland.
Justin van BreenAPC Microbiome Ireland, University College Cork, Cork, Ireland.
Barry SchoemakerFrieslandCampina, Amersfoort, Netherlands.
Linqiu CaoFrieslandCampina, Amersfoort, Netherlands.
Bas KuipersFrieslandCampina, Amersfoort, Netherlands.
Mary O'Connell MotherwayAPC Microbiome Ireland, University College Cork, Cork, Ireland.
Margriet SchotermanFrieslandCampina, Amersfoort, Netherlands.
Douwe van SinderenAPC Microbiome Ireland, University College Cork, Cork, Ireland.
FrieslandCampina (Netherlands) · NLUniversity College Cork · IEAPC Microbiome Institute · IEMunster Technological University · IE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Galacto-oligosaccharides (GOS) represent non-digestible glycans that are commercially produced by transgalactosylation of lactose, and that are widely used as functional food ingredients in prebiotic formulations, in particular in infant nutrition. GOS consumption has been reported to enhance growth of specific bacteria in the gut, in particular bifidobacteria, thereby supporting a balanced gut microbiota. In a previous study, we assessed the hydrolytic activity and substrate specificity of seventeen predicted β-galactosidases encoded by various species and strains of infant-associated bifidobacteria. In the current study, we further characterized seven out of these seventeen bifidobacterial β-galactosidases in terms of their kinetics, enzyme stability and oligomeric state. Accordingly, we established whether these β-galactosidases are capable of synthesizing GOS via enzymatic transgalactosylation employing lactose as the feed substrate. Our findings show that the seven selected enzymes all possess such transgalactosylation activity, though they appear to differ in their efficiency by which they perform this reaction. From chromatography analysis, it seems that these enzymes generate two distinct GOS mixtures: GOS with a relatively short or long degree of polymerization profile. These findings may be the stepping stone for further studies aimed at synthesizing new GOS variants with novel and/or enhanced prebiotic activities and potential for industrial applications.

Indexed as

Bifidobacteriumbifidogenicgalacto-oligosaccharidesgut microbiotainfantmicrobiomeoligosaccharidesprebiotics

Identifiers

PMID34012427
PMCPMC8126724
OpenAlexW3157282231

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.